ahlam1399
07-24-2015, 06:32 PM
AstraZeneca chases biosimilar Avastin drug with Japanese group
LONDON (Reuters) - AstraZeneca is dipping its toe in the biosimilars market, as a way to make future cancer drug cocktails more affordable, by linking with a Japanese group to develop a copy of Roche's blockbuster medicine Avastin.
http://rc.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/rc/1/rc.img (http://rc.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/rc/1/rc.htm)
http://rc.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/rc/2/rc.img (http://rc.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/rc/2/rc.htm)
http://rc.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/rc/3/rc.img (http://rc.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/rc/3/rc.htm)
http://da.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/a2.img (http://da.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/a2.htm)
http://adchoice.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/ach.img (http://adchoice.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/ach.htm)http://pi.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/a2t.imghttp://pi2.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/48684925/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=91MJMSSznPs:RiIPg8khF5Y:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=91MJMSSznPs:RiIPg8khF5Y:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=91MJMSSznPs:RiIPg8khF5Y:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=91MJMSSznPs:RiIPg8khF5Y:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=91MJMSSznPs:RiIPg8khF5Y:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/91MJMSSznPs
LONDON (Reuters) - AstraZeneca is dipping its toe in the biosimilars market, as a way to make future cancer drug cocktails more affordable, by linking with a Japanese group to develop a copy of Roche's blockbuster medicine Avastin.
http://rc.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/rc/1/rc.img (http://rc.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/rc/1/rc.htm)
http://rc.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/rc/2/rc.img (http://rc.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/rc/2/rc.htm)
http://rc.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/rc/3/rc.img (http://rc.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/rc/3/rc.htm)
http://da.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/a2.img (http://da.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/a2.htm)
http://adchoice.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/ach.img (http://adchoice.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/ach.htm)http://pi.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/a2t.imghttp://pi2.feedsportal.com/r/234566064887/u/49/f/654207/c/35217/s/48684925/sc/28/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/48684925/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=91MJMSSznPs:RiIPg8khF5Y:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=91MJMSSznPs:RiIPg8khF5Y:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=91MJMSSznPs:RiIPg8khF5Y:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=91MJMSSznPs:RiIPg8khF5Y:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=91MJMSSznPs:RiIPg8khF5Y:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/91MJMSSznPs